Panel Discussion: Advancing Scalable Gene Editing Manufacturing & CDMO Collaboration to Preserve Product Quality & Reduce Timelines
- Streamlining manufacturing and analytical collaboration to preserve product purity, potency, and consistency throughout scale-up
- Optimizing CDMO partnerships and tech transfer strategies to reduce development delays and manufacturing inefficiencies
- Exploring flexible guide RNA manufacturing approaches to support scalable production across diverse rare disease populations